{"log_id": 4176527537911564210, "direction": 0, "words_result_num": 29, "words_result": [{"probability": {"variance": 0.003122, "average": 0.98026, "min": 0.696158}, "location": {"width": 781, "top": 229, "height": 32, "left": 254}, "words": "阿德福韦耐药相关rtA181V和/或rtN236T突变的HBV病毒株对替诺福韦的敏感性"}, {"probability": {"variance": 1e-06, "average": 0.997922, "min": 0.997122}, "location": {"width": 42, "top": 239, "height": 27, "left": 1119}, "words": "国家"}, {"probability": {"variance": 0.001167, "average": 0.989363, "min": 0.806351}, "location": {"width": 822, "top": 273, "height": 29, "left": 214}, "words": "为野生型病毒的2.9至10倍,携带rtA181T突变基因的病毒株对替诺福韦的敏感性为"}, {"probability": {"variance": 1.7e-05, "average": 0.998414, "min": 0.98383}, "location": {"width": 267, "top": 317, "height": 27, "left": 212}, "words": "野生型病毒的0.9至1.5倍"}, {"probability": {"variance": 9.4e-05, "average": 0.995207, "min": 0.953331}, "location": {"width": 772, "top": 360, "height": 33, "left": 255}, "words": "研究0102、0103、0106、0108和0121中有152名受试者在开始接受富马酸替诺"}, {"probability": {"variance": 6.3e-05, "average": 0.995993, "min": 0.965827}, "location": {"width": 824, "top": 404, "height": 33, "left": 211}, "words": "福韦二吡呋酯治疗时HBV携带已知对HBV核苷/核苷酸类似物逆转录酶抑制剂耐药的突"}, {"probability": {"variance": 0.000638, "average": 0.987855, "min": 0.866573}, "location": {"width": 809, "top": 448, "height": 29, "left": 211}, "words": "变基因:14名携带阿德福韦耐药相关突变基因(rtA181S/T/V和/或rtN236T),135"}, {"probability": {"variance": 0.002241, "average": 0.986208, "min": 0.775307}, "location": {"width": 817, "top": 491, "height": 33, "left": 212}, "words": "名携带拉米夫定耐药相关突变基因(rtM204I/V),3名携带阿德福韦和拉米夫定耐药"}, {"probability": {"variance": 0.001878, "average": 0.98686, "min": 0.800226}, "location": {"width": 807, "top": 533, "height": 35, "left": 212}, "words": "相关突变基因。在使用富马酸替诺福韦二吡呋酯治疗长达240周后,11/14名阿德福"}, {"probability": {"variance": 0.000497, "average": 0.990893, "min": 0.897524}, "location": {"width": 805, "top": 577, "height": 34, "left": 213}, "words": "韦耐药HBV受试者、124/135名拉米夫定耐药HBV受试者和2/3名阿德福韦和拉米夫"}, {"probability": {"variance": 0.000191, "average": 0.9952, "min": 0.918369}, "location": {"width": 811, "top": 620, "height": 33, "left": 212}, "words": "定耐药HBV受试者均达到并维持病毒抑制( HBV DNA小于400拷贝数/mL)。3/5名携"}, {"probability": {"variance": 0.001191, "average": 0.980567, "min": 0.872669}, "location": {"width": 547, "top": 664, "height": 30, "left": 212}, "words": "带rtA181T/V和rtN236T突变病毒的受试者仍有病毒血症"}, {"probability": {"variance": 7.1e-05, "average": 0.994272, "min": 0.979756}, "location": {"width": 89, "top": 708, "height": 27, "left": 212}, "words": "毒理研究"}, {"probability": {"variance": 1e-06, "average": 0.999186, "min": 0.997166}, "location": {"width": 88, "top": 751, "height": 27, "left": 211}, "words": "遗传毒性"}, {"probability": {"variance": 3.6e-05, "average": 0.997415, "min": 0.973324}, "location": {"width": 756, "top": 793, "height": 35, "left": 254}, "words": "富马酸替诺福韦二吡呋酯在体外小鼠淋巴试验中能导致基因突变,在Ames试验"}, {"probability": {"variance": 0.000248, "average": 0.99399, "min": 0.924356}, "location": {"width": 817, "top": 836, "height": 33, "left": 211}, "words": "中结果为阴性。在一项体内小鼠微核试验中,富马酸替诺福韦二吡呋酯对雄性小鼠给"}, {"probability": {"variance": 0, "average": 0.999645, "min": 0.999208}, "location": {"width": 132, "top": 880, "height": 27, "left": 211}, "words": "药结果为阴性"}, {"probability": {"variance": 0, "average": 0.999535, "min": 0.999244}, "location": {"width": 89, "top": 964, "height": 25, "left": 211}, "words": "生殖毒性"}, {"probability": {"variance": 0.003288, "average": 0.984939, "min": 0.656115}, "location": {"width": 778, "top": 1005, "height": 36, "left": 253}, "words": "根据体表面积比较,在大鼠中以相当于人10倍的剂量给予富马酸替诺福韦二吡呋"}, {"probability": {"variance": 0.000158, "average": 0.996069, "min": 0.924151}, "location": {"width": 808, "top": 1050, "height": 30, "left": 209}, "words": "酯,雄性大鼠在交配前连续28天给予药物、雌性大鼠在交配前到妊娠第7天连续15"}, {"probability": {"variance": 5.2e-05, "average": 0.996292, "min": 0.96063}, "location": {"width": 810, "top": 1092, "height": 32, "left": 211}, "words": "天给予药物,结果显示富马酸替诺福韦二吡呋酯对生育能力、交配行为和早期胚胎发"}, {"probability": {"variance": 0.000145, "average": 0.995407, "min": 0.939212}, "location": {"width": 553, "top": 1135, "height": 28, "left": 210}, "words": "育均未见影响。然而,在雌性大鼠中出现发情周期的改变"}, {"probability": {"variance": 0, "average": 0.999286, "min": 0.998705}, "location": {"width": 70, "top": 1177, "height": 26, "left": 208}, "words": "致癌性"}, {"probability": {"variance": 0.000225, "average": 0.996347, "min": 0.909709}, "location": {"width": 768, "top": 1218, "height": 30, "left": 254}, "words": "在小鼠和大鼠中进行了富马酸替诺福韦二吡呋酯的长期经口给药致癌性研究,暴"}, {"probability": {"variance": 0.002224, "average": 0.987433, "min": 0.768737}, "location": {"width": 826, "top": 1257, "height": 33, "left": 209}, "words": "露水平最高大约分别为人体HIV-1感染治疗剂量的16倍(小鼠)和5倍(大鼠)。"}, {"probability": {"variance": 0.000484, "average": 0.991643, "min": 0.90239}, "location": {"width": 805, "top": 1303, "height": 30, "left": 210}, "words": "雌性小鼠在高剂量下(暴露水平比人高16倍)肝脏腺瘤增加。大鼠最高暴露水平是"}, {"probability": {"variance": 0, "average": 0.999391, "min": 0.998333}, "location": {"width": 309, "top": 1345, "height": 29, "left": 209}, "words": "人治疗剂量5倍时,未见致癌性"}, {"probability": {"variance": 0.003229, "average": 0.966936, "min": 0.86852}, "location": {"width": 93, "top": 1388, "height": 27, "left": 208}, "words": "其它毒性"}, {"probability": {"variance": 0, "average": 0.990145, "min": 0.990145}, "location": {"width": 16, "top": 1496, "height": 21, "left": 1017}, "words": "3"}], "language": 3}